Klin Farmakol Farm. 2016;30(2):29-31 | DOI: 10.36290/far.2016.016

Vitamin D and multiple sclerosis

Kateřina Langmaierová1,2, Marta Vachová1,3
1 Krajská zdravotní a. s., Nemocnice Teplice, Neurologické oddělení
2 Lékárna U Anděla, Teplice
3 MS Centrum, Teplice

Multiple sclerosis is often referred to as a disease of the temperate zones. The incidence of multiple sclerosis in the population

correlates with the distance from the equator. In this context, association of the occurrence of this disease is examined with

the actual level of vitamin D in the human organism. The article explores the relationship between vitamin D deficiency and the

relapses of multiple sclerosis. It summarises the development of findings in this area in the recent years.

Keywords: multiple sclerosis, vitamin D

Published: September 19, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Langmaierová K, Vachová M. Vitamin D and multiple sclerosis. Klin Farmakol Farm. 2016;30(2):29-31. doi: 10.36290/far.2016.016.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vachová M. Symptomatická léčba roztroušené sklerózy. Postgraduální medicína [online]. 2012; 2012(9): 36-42 [cit. 2016-03-26]. Dostupné z: http://zdravi.e15.cz/clanek/postgradualni-medicina/symptomaticka-lecba-roztrousene-sklerozy-467515.
    2. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Research [online]. 2010; 20(10): 1352-1360 [cit. 2016-03-11]. DOI: 10.1101/gr.107920.110. ISSN 10889051. Dostupné z: http://genome.cshlp.org/cgi/doi/10.1101/gr.107920.110. Go to original source... Go to PubMed...
    3. Michalík J, Čierny D, Lehotský J, Kurča E. Vybrané biologické a biochemické markery sclerosis multiplex. Neurologie pro praxi. 2014; 15(2): 68-70.
    4. Křížová L, Kollár B, Čarnická Z. Genetické a environmentálne faktory zapojené do patogenézy sklerózy multiplex. Česká a slovenská neurologie a neurochirurgie. 2013; 76(4): 430-437.
    5. Simon KC, Munger KL, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis [online]. 2010; 16(2): 133-138 [cit. 2016-03-28]. DOI: 10.1177/1352458509355069. ISSN 13524585. Dostupné z: http://msj.sagepub.com/cgi/doi/10.1177/1352458509355069. Go to original source... Go to PubMed...
    6. Niino M, Fukazawa T, Kikuchi S, Sasaki H. Therapeutic Potential of Vitamin D for Multiple Sclerosis. Current Medicinal Chemistry. 2008; 15(5): 499-505. Go to original source... Go to PubMed...
    7. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Reviews Immunology [online]. 2008; 8(9): 685-698 [cit. 2016-03-26]. DOI: 10.1038/nri2378. ISBN 10.1038/nri2378.Dostupné z: http://www.nature.com/doifinder/10.1038/nri2378. Go to original source... Go to PubMed...
    8. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Vitamin D in take and incidence of multiple sclerosis. Neurology [online]. 2004 Jan; 62(1): 60-65 [cit. 2016-03-11]. Dostupné z: www. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.328.9213&rep=rep1&type=pdf. Go to original source... Go to PubMed...
    9. Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurology [online]. 2014; 71(3): 306-314 [cit. 2016-03-13]. DOI: 10.1001/jamaneurol.2013.5993. ISSN 21686157. Dostupné z: http://nlk.summon.serialssolutions.com. Go to original source... Go to PubMed...
    10. Friedecký B, Vávrová J. Současný stav stanovení vitaminu D v séru in Klin. Biochem. Metab., 20(41), 2012; No. 3, 174-117.
    11. Holick MF, Chen TC. Vitamin D deficiency: a world wide problem with health. Am J Clin Nutr [online]. 2008; 87(suppl.), 1080S-1086S [cit. 2016-03-26]. Dostupné z: http://www.medvik.cz/. Go to original source... Go to PubMed...
    12. Holick MF. Optimal Vitamin D Status for the Prevention and Treatment of Osteoporosis. Drugs Aging [online]. 2007; 24(12): 1017-1029 [cit. 2016-03-10]. Dostupné z: www.medvik.cz. Go to original source... Go to PubMed...
    13. Becklund BR, Severson KS, Vang SV, Deluca HF. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proceedings of the National Academy of Sciences [online]. 2010; 107(14): 6418-6423 [cit. 2016-03-26]. DOI: 10.1073/pnas.1001119107. ISSN 00278424. Dostupné z: http://www.pnas.org/cgi/doi/10.1073/pnas.1001119107. Go to original source... Go to PubMed...
    14. Kimball SM, Ursell MR, O'Connor P,Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr [online]. 2007; 86(3): 645-651 [cit. 2016-02-26]. Dostupné z: http://ajcn.nutrition.org/content/86/3/645.full.pdf+html. Go to original source... Go to PubMed...
    15. Vieth R, Kimball SM, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequatein take versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutrition Journal [online]. 2004; 3(1): 8-18 [cit. 2016-03-26]. DOI: 10.1186/1475-2891-3-8. ISSN 14752891. Dostupné z: http://www.nutritionj.com/content/3/1/8. Go to original source... Go to PubMed...
    16. Golan D, Halhal B, Glass-Marmor L, et al. Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties. BMC Neurology [online]. 2013; 13(1): 60- [cit. 2016-03-26]. DOI: 10.1186/1471-2377-13-60. ISSN 14712377. Dostupné z: http://www.biomedcentral.com/1471-2377/13/60. Go to original source... Go to PubMed...
    17. Fitzgerald KC, Munger KL, Kochert K, et al. Association of Vitamin D Levels With Multiple SclerosisActivity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurology [online]. 2015; 72(12): 1458-65 [cit. 2016-03-13]. DOI: 10.1001/jamaneurol.2015.2742. ISSN 21686157. Dostupné z: http://nlk.summon.serialssolutions.com/. Go to original source... Go to PubMed...
    18. Munger KL, Ascherio A. Prevention and treatment of MS: studying the effects of vitamin D. Multiple Sclerosis Journal [online]. 2011; 17(12): 1405-1411 [cit. 2016-03-26]. DOI: 10.1177/1352458511425366. ISSN 13524585. Dostupné z: http://msj.sagepub.com/cgi/doi/10.1177/1352458511425366. Go to original source... Go to PubMed...
    19. Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelmann D, Ascherio A. Dietary in také of vitamin D during adolescence and risk of multiple sclerosis. Journal of Neurology [online]. 2011; 258(3): 479-485 [cit. 2016-03-28]. DOI: 10.1007/s00415-010-5783-1. ISSN 03405354. Dostupné z: http://link.springer.com/10.1007/s00415-010-5783-1. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.